Stonehage Fleming Financial Services’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-220
Closed -$9.94K 236
2024
Q3
$9.94K Hold
220
﹤0.01% 201
2024
Q2
$10.8K Hold
220
﹤0.01% 209
2024
Q1
$3.32K Hold
220
﹤0.01% 167
2023
Q4
$8.11K Hold
220
﹤0.01% 213
2023
Q3
$4.46K Buy
+220
New +$4.83K ﹤0.01% 235
2023
Q2
Sell
-220
Closed -$3.32K 239
2023
Q1
$3.32K Hold
220
﹤0.01% 167
2022
Q4
$5.24K Hold
220
﹤0.01% 163
2022
Q3
$7K Hold
220
﹤0.01% 182
2022
Q2
$8K Buy
+220
New +$7.79K ﹤0.01% 238

Other funds holding TWST

Stonehage Fleming Financial Services's TWST Position: Q4 2024 in Review

Stonehage Fleming Financial Services sold out of Twist Bioscience (TWST) in Q4 2024, closing a stake of 220 shares — an estimated $9.94K sold.

Stonehage Fleming Financial Services first reported a position in TWST in Q2 2022 and held it in 9 quarters. The position peaked at $10.8K in Q2 2024. 246 funds tracked by Wall St. Rank hold TWST as of Q4 2024.

  • Stonehage Fleming Financial Services reported no remaining Twist Bioscience position as of Q4 2024 after selling out during the quarter.
  • Stonehage Fleming Financial Services sold 220 Twist Bioscience shares in Q4 2024, an estimated $9.94K.
  • Stonehage Fleming Financial Services first reported a position in Twist Bioscience in Q2 2022 and held it in 9 quarters.
  • Stonehage Fleming Financial Services's Twist Bioscience position peaked at $10.8K in Q2 2024.
  • 246 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2024.

Based on Stonehage Fleming Financial Services's 13F filing for Q4 2024, filed 22 Jan 2025.